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Ultra running, a sport that consists of races above the marathon marker of 26.2 miles, has
rarely been studied in depth. Little peer-reviewed scientific information examines the
morbidity or disease prevalence associated with long-distance ultrarunning. Furthermore,
there is an increase in reports of rhabdomyolysis within the ultrarunning community,
which may coincide with an increase in the demand for long-distance ultrarunning races.
This study examined the rate of hospital or emergency room admissions with a diagnosis
of rhabdomyolysis and assesses if the incidence of rhabdomyolysis events in young males
parallels the growth of ultrarunning. We hypothesized that:
•

ED diagnoses of rhabdomyolysis in young adult males parallel the growth
in ultrarunning.

•

There are geographic and seasonal variations in the population rate of ER,
which correspond to locations and times where most training for
ultrarunning events occurs.

A regression test to trend the races & rhabdomyolysis frequencies/rates over time was
conducted using patient data from NIS database and racing data from Ultrarunning.com.
Our research has demonstrated a rise in the rates of rhabdomyolysis that mirror the rise of
long-distance ultra running in young adult males.
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CHAPTER 1
INTRODUCTION
Background and Need
There is little peer-reviewed scientific information available on morbidity or disease
prevalence associated with long-distance ultrarunning. Ultrarunning, also known as
ultramarathoning, is defined by UltraRunning Magazine (2013) as:
“…anything past the marathon, or 26.2 miles. However, the shortest standard
distance that is considered an ultra is the 50 kilometer distance, or 31.07 miles.
Other standard distances are the 50 mile, 100 mile, 100 km, and a series of events
that last for specified time periods such as 6 hour, 12 hour, 24 hour, 48 hour, and
6 days” (para. 1).
Discussions and details about morbidity and adverse effect occurrences have been
disseminated through informal forums, most recently, through social media. Social media
became the platform to really push the ultrarunning agenda and increase popularity of the
sport. According to Seiss (2012), “the number of [ultrarunning] trail races has more than
tripled since 2000 to 2,400 events, and the number of participants has grown from 90,000
to 230,000” (para. 6). Furthermore, “UltraRunning Magazine reported the number of
runners who finished ultra-length trail races increased from 15,500 in 1998 to 52,000 in
2011” (Seiss, 2012, para. 6). Thus, the sport of ultrarunning is clearly diffusing into the
mainstream of running.
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One adverse event that may be associated with ultrarunning is rhabdomyolysis.
Rhabdomyolysis can have several causes, however exertional rhabdomyolysis (ER) in
ultrarunning is an overuse injury that results from breakdown and necrosis of striated
skeletal muscle and cell death. The resulting release of intracellular content causes
muscle pain and swelling and may result in acute renal failure, intravascular coagulation,
cardiac arrhythmia and death (Tietze and Borchers, 2014). Thus, rapid diagnosis and
treatment is required for severe rhabdomyolysis. Information about rhabdomyolysis
prevalence in young males in the peer-reviewed literature is sparse and is frequently
linked to social media reports. An Ovid/MEDLINE search produces only twenty-seven
articles related to running and rhabdomyolysis, and a refined search produces twenty-two
papers when narrowing the parameters by males only.
There is an increase in reports of rhabdomyolysis within the ultrarunning community,
which may coincide with an increase in long-distance ultrarunning races over the last 10
years. There were reports of 293 races in 2004 with growth to 1296 in 2014 (n.d., 10 year
growth of ultrarunning events and races, 2014). This can also be illustrated through the
ratio of races to events, which has increased from 1.25 in 2004 to 1.53 to 2014; a 20%
ascension (n.d., 10 year growth of ultrarunning events and races, 2014). “Events are
defined as an individual contest, whereas races are the number of races (of varying
distances) at each event (n.d., 10 year growth of ultrarunning events and races, 2014).
The UltraRunning website also details a gender breakdown by finishes which shows male
finishers making up 98.46% in 1978 to a decrease of 69.21% in 2014 (n.d., Ultrarunning
finishes by gender , 2014). However, even with this gender shift, more than two thirds of
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ultrarunners are male, and little is known about the incidence of rhabdomyolysis within
this population.
Problem Statement
The incidence of severe, potentially life threatening cases of exertional rhabdomyolysis
has not been extensively studied within the sport of ultrarunning. This study will examine
the rate of hospital or emergency room admissions with a diagnosis of rhabdomyolysis
and assess if the incidence of rhabdomyolysis events in young males parallels the growth
of ultrarunning, defined as events longer than a marathon distance of 26.2 miles.
Research Questions and Research Hypothesis
The primary research question is do ten year trends in emergency department (ED)
diagnoses of exertional rhabdomyolysis in young adult males parallel the growth in long
distance ultrarunning? We hypothesize that:
1. ED diagnoses of rhabdomyolysis in young adult males parallel the growth in
ultrarunning.
2. There are geographic and seasonal variations in the population rate of ER, which
correspond to locations and times where most training for ultrarunning events
occurs.
Population
We will use the National Inpatient Sample (NIS) data set, which is part of the Healthcare
Cost and Utilization Project (HCUP) hospital discharge data set, as developed by the
Agency for Health Care Research and Quality (AHRQ). The NIS provides a national
sample of hospital admissions. We will examine data for the years 2000 through 2012.
The population for this study will consist of young adult males who present to the ED
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with a primary diagnosis of exertional rhabdomyolysis. Young adult males will be
limited to men, 18 to 40 years of age. ER will be defined by an emergency admission to
the hospital with an ICD-9 code of 728.88. Population rates for admissions for ER will be
calculated using the census count of each states population of males age 18-40. Patients
who may be likely to present with rhabdomyolysis, which is non-exertional, will be
excluded from our sample.

ii

CHAPTER 2
LITERATURE REVIEW

Introduction
Upon review of the literature, a quantitative approach to the subject of “Do Ten Year
Trends in Hospital Emergency Diagnosis of Rhabdomyolysis for Young Males Parallel
Growth in Ultrarunning” has begun to emerge. Skenderi, Kavouras, Anastasiou,
Yiannakouris, and Matalas (2006) used blood analysis, and statistical analysis to describe
their results. In their study, “Pre and post-race values were compared by paired t-tests.
The relationship of finishing time with liver and muscle damage markers was tested by
performing single regression analysis” (Skenderi, Kavouras, Anastasiou, Yiannakouris, &
Matalas, 2006, p. 1055). Another study produced a similar use of quantitative data and
analysis to display their results. McCullough et al. (2010), used blood urea nitrogen and
serum creatinine levels to describe the increase in these markers in runners post marathon
racing. Statistically, McCullough et al.’s (2010) data had comparisons that “…were made
using the paired two-sample t-test or the paired Wilcoxon rank sum test for variables that
were not normally distributed” (p. 195).
Numerous design methods have been used in previous research and case studies. Mettler,
Rusch, Frey, Bestman, Wenk, and Colombani (2008) wrote an article titled
“Hyponatremia Among Runners in the Zurich Marathon”, which used an experimental
design to describe their process and research. The authors recruited runners during the
pre-race procession where they took blood samples to test plasma sodium levels, weight
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measurements, and fluid intake. Statistical analyses were performed using linear
correlation plots with the SigmaPlot software program and the Statistical Analysis
System (SAS) (Mettler, et al., 2008). In another study, Knechtle et al.’s (2011) used an
observational field approach and again drew blood samples from runners’ pre, during,
and post-race. In this study, the authors also took urine samples and weight
measurements. For statistical analyses, “Bonferroni-corrected paired t-tests were applied
to detect a significant change from one period to the other” (Knechtle, et al., 2011, p.
228). Typically, studies are quantitative in structure with observational assessments to
support the data.
In much of the research, authors measured quantitative variables using statistical analysis
and biological samples. “Because of the small sample size, the Friedman test was used to
determine changes in biochemical data from plasma and urine specimens at prerace,
immediately postrace, and 1 day postrace” (Kao, et al., 2014, p. 2). As with most studies,
a specific software program was used for statistical analysis. In the case of Kao et al.’s
study, SPSS 18.0 was used (Kao, et al., 2014). Along with the statistical methods used to
aggregate the data, field observational variables were captured. Both prospective and
retrospective captures of the qualitative data were described in the literature. Study
questions were also noted to be similar in structure and presentation. Kao et al.’s study
boasted the title “Effects of 100-km Ultramarathon on Acute Kidney Injury” while
Knechtle et al.’s study was titled “Prevalence of Exercise-Associated Hyponatremia in
Male Ultraendurance Athletes.” Most studies did not possess a question in their title but
used a statement instead. The question(s) were typically generated in the body of the
studies. For example, Mydlik, Derzsiova, and Bohus (2012) in their paper “Renal
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Function Abnormalities After Marathon Run and 16-Kilometre Long-Distance Run”
asked what are the essential renal functions in runners before and immediately after the
marathon run and after the 16-kilometre run at the end of the introduction (Mydlik,
Derzsiova, & Bohus, 2012).
For this literature review, the following databases were searched: PubMed, Cochrane,
Google Scholar, and Scopus. Key words used in the search strategy included:
-

run(ing)

-

marathon(s)

-

ultramarathon(s)

-

ultrarun(ing)

-

rhabdomyolysis

-

acute renal failure

-

kidney injury

Filters and limits (e.g., article type, publication date, age, etc.) included:
-

articles in English

-

published within the last 20 years

-

research-based

-

patients aged 20-40 years’ old

-

males

Rhabdomyolysis
Rhabdomyolysis, as defined by Tietze and Borchers (2014), is “…the breakdown and
necrosis of striated skeletal muscle after engaging in physical activity” (p. 336). Skeletal
muscle cell damage and death can be attributed to several different mechanisms but the
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common final pathway is characterized by an elevation in intracellular free ionized
calcium levels that are higher than normal in cytoplasm and mitochondria (Tietze &
Borchers, 2014). The causes of rhabdomyolysis have historically been associated with
traumatic conditions, but recently, non-traumatic conditions have become more prevalent
(Efstratiadis, et al., 2007). According to Efstratiadis, Voulgaridou, Nikiforou, Kyventidis,
Kourkouni, and Vergoulas (2007), seizures, drug and alcohol abuse, the crush syndrome,
and specific metabolic derangements are the most common factors that lead to
rhabdomyloysis (p. 129). Table One outlines the different causes of rhabdomyolysis.
Table 1
Physical Exertion

Intense physical activity; tetanus; electric
shock; severe agitation; status epilepticus

Direct Muscle Injury

Natural disasters; industrial & car accidents;
crush trauma; deep burns; lightening injury;
physical abuse

Muscle Ischemia

Generalized ischemia; shock; air emboli;
arterial thrombosis; vascular occlusion during
operation; sickle cell crisis; prolonged
immobilization; crush injury syndrome;
reperfusion injury; compartment syndrome

Temperature Extremes

Frostbite injuries; hypothermia; heat stroke;
malignant hyperthermia; malignant
neuroleptic syndrome; serotonergic syndrome
Ethanol; drugs of abuse; statins; fibrates;
anesthetic drugs; salicylates; antibiotics;
chemotherapeutics; immunosuppressants;
corticosteroids; antipsychotics;
antidepressants; venoms
Hypokalemia; hyponatremia;
hypophosphatemia; hypernatremia;
hyperglycemic hyperosmolar non ketoic
coma; diabetic ketoacidosis;
Addison disease; hyperaldosteronism;
pheochromocytoma; thyrotoxicosis;
hypothyroidism

Drugs-Toxins-Venoms

Metabolic

Endocrinologic
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Genetic
Infectious
Autoimmune
(Efstratiadis, et al., 2007).

Metabolic myopathies; muscular dystrophies
Viral; bacterial; parasitic
Polymyositis; dermatomyositis

For the purpose of this research, exercise induced rhabdomyolysis is of particular interest.
Specifically, symptomatic athletes may present with the following complaints post
physical activity:


Pain



Tenderness



Weakness



Muscle swelling
(Tietze & Borchers, 2014)

Researchers Tietze and Borchers (2014) categorize athletes into two brackets as it
pertains to their probability of being diagnosed with exertional rhabdomyolysis: high-risk
and low-risk. Table 2 provides the attributes associated with each category.
Table 2
High-Risk Athletes
Delayed recovery (longer than 1 week)

Low-Risk Athletes
Rapid clinical recovery and creatine kinase
(CK) normalization after exercise
restrictions
Persistent elevation of CK despite rest for 2 Sufficiently fit or well-trained athlete with
weeks
a history of intense training/exercise
Acute renal injury to any degree
No personal or family history of
rhabdomyolysis
Personal or family history of exertional
Existence of other group or team-related
rhabdomyolysis
cases of exertional rhabdomyolysis during
the same exercise sessions
Personal or family history of recurrent
Suspected or documented concomitant
muscle cramps
viral illness
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Personal or family history of malignant
hyperthermia

Ingestion of a drug or dietary supplement
that could contribute to the development of
exertional rhabdomyolysis

Personal or family history of sickle cell
trait
Muscle injury after low to moderate
workout activity
Personal history of significant heat injury
Serum CK peak of greater than 100,000
upper limit (U/L)
(Tietze & Borchers, 2014)
Athletes may be predisposed to exertional rhabdomyolysis due to changes in their
workout routines, sickle cell anemia, certain medications (both stimulants and NSAIDs),
any preexisting illness, and autoimmune or metabolic disorders (Tietze & Borchers,
2014). Athletes can develop hematologic profiles that are consistent with exertional
rhabdomyolysis but may not develop the clinical condition (Tietze & Borchers, 2014).
Hematologic, and other blood profiles, are groups of tests that measure different
chemicals and/or disorders (National Institutes of Health, 2012). A study of ultramarathon runners showed myoglobinuria in 25 of 44 participants with a mean increase in
creatinine kinase of 2400 U/L 48 hours post-race (Tietze & Borchers, 2014). In this
study, none of the ultra-marathoners developed any clinical symptoms of exertional
rhabdomyolysis or renal failure (Tietze & Borchers, 2014). The Consortium for Health
and Military Performance (CHAMP) provides guidelines for when to return to sport
following a diagnosis of exertional rhabdomyolysis. The CHAMP guidelines follow three
phases:
Phase 1


Rest for 72 hours and encouragement of oral hydration
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8 hours of sleep nightly



Remain in a thermally controlled environment if the episode of ER was in
relation to heat illness



Follow-up after 72 hours with a repeat serum CK level and urinalysis
(UA)



If the CK has dropped to below 5 times the upper limit of normal and the
UA is negative, the athlete can progress to phase 2; if not, reassessment in
72 additional hours is warranted



Should the UA remain abnormal or the CK remain elevated for 2 weeks,
expert consultation is recommended

Phase 2


Begin light activities, no strenuous activity



Physical activity at own pace/distance



Follow-up with a care provider in 1 week



If there is no return of clinical symptoms, the athlete can progress to phase
3; if not, the athlete should remain in phase 2 checking with the health
care professional every week for reassessment; if muscle pain persists
beyond the fourth week, consider expert evaluation to include psychiatry

Phase 3


Gradual return to regular sport/physical training



Follow-up with care provider as needed
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(Tietze & Borchers, 2014)
The CHAMP recommendations provide a framework for returning to sports, but there are
no hard, evidence-based guidelines according to Tietze and Borchers (2014). Skenderi,
Kavouras, Anastasiou, Yiannakouris, and Matalas’ (2006) study was “…the first to
investigate the influence of continuous, moderate-intensity, ultraendurance exercise on
the status of skeletal muscle and hepatic enzymes” (p. 1055) but does not definitively
assess the prevalence of rhabdomyolysis. Their study focused largely on the change in
blood serum levels, particularly creatine kinase and provides a table that depicts the
relationship between finishing time and serum creatine kinase activity post-race:

(Skenderi, Kavouras, Anastasiou, Yiannakouris, & Matalas, 2006).
Mettler, Rusch, Frey, Bestman, Wenk, and Colombani (2008) recruited runners during
the pre-race procession where they took blood samples to test plasma sodium levels,
weight measurements, and fluid intake. Data were analyzed using linear correlation plots
with the SigmaPlot software program and the Statistical Analysis System (SAS) (Mettler,
et al., 2008). Knechtle et al. (2011) used an observational field approach and again drew
blood samples from the runners but drew these samples pre, during, and post-race. In this
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study, the authors also drew urine samples and weight measurements.
Hew-Butler et al. (2015) discussed the reported incidences of asymptomatic and
symptomatic exercise-assciated hyponatremaia (EAH). The authors noted a race where
the incidences of asymptomatic EAH ranged from 0% to 51% (Hew-Butler, et al., 2015).
Specifically, an ultramarathon yieled a 67% incidence rate of hyponatremic racers who
were asymptomatic at some point during the race (Hew-Butler, et al., 2015). However,
only 27% of the racers finished with a serum sodium level <135 mmol/L, which is
considered to be below the normal range. Less common are the incidences of
symptomatic EAH. Hew-Butler et al (2015) reported that only a few these cases have
occurred in marathons, Ironman triathlons, ultramarathons, and military training
exercises. Reports of incidnces in symptomatic EAH have been as high as 23% and 38%
in athletes seeking care during an Ironman Triathlon and ultramarathon, but most
endurance events report no cases, especially in distances at the marathon length or shorter
(Hew-Butler, et al., 2015). In a study that examined large samples of data, 669 161-km
ultramarathon runners or 0.1% of the study’s participants presented with symptomatic
EAH during the 5-year sampling period (as compared to 13% who were aysmptomatic
EAH) (Hew-Butler, et al., 2015). However, “…considering the total number of race
participants over this time period, the actual incidence of symptomatic EAH was
approximately 0.06%” (Hew-Butler, et al., 2015, p. 306). Lastly, the authors provided a
table outlining the risk factors for the development of EAH, which includes:


Overdrinking water, sports drinks, and other hypotonic beverages



Weight gain during exercise



Exercise duration >4 h
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Event inexperience or inadequate training



Slow running or performance pace



High or low body mass index (BMI)



Readily available fluids
(Hew-Butler, et al., 2015).

A separate study by Knechtle et al. (2011) examined the prevalence of EAH in male
ultraendurance athletes. Of the 95 ultramarathoners and the 25 mountain
ultramarathoners in their study, five of the ultramarthoners (5%) deveopled asymptomatic
EAH, while 2 mountain ultramarathoners developed symptomatic EAH (Knechtle, et al.,
2011). None of the mountain ultramarathoners demonstrated any clinical signs, and the
prevalence of EAH was 8% (2 of 25) (Knechtle, et al., 2011). The authors concluded the
prevalence of EAH would be higher in ultraendurance athletes due to the slower running
pace and increaed fluid intake. However, data aggregation from all athletes in the study
showed no significant statistical prevelance of EAH in ultraendurance athletes as
compared to existing reports involving martathoners, Ironman triathletes, and
ultramarathoners (Knechtle, et al., 2011).
Alpers and Jones (2010) conducted a military-based study that examined the incidence of
rhabdomyolysis. They performed a descriptive retrospective case series with patients that
were diagnosed with rhabdomyolysis from May 2002 to September 2007. The case series
was constructed by using a diagnostic code-based search into the Wilford Hall Medical
Center’s records which included both military and non-miltary patients (Alpers & Jones,
2010). These cases were organized according to causes that met the case definition of
exertional rhabdomyolysis as listed below:
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Causes of 177 cases of rhabdomyolysis
Cause
Exertion
Trauma
Toxin
Unknown
Infection
Heat Illness
Seizure
Genetic (metabolic myopathy)
Endocrine
Multiple Causes
(Alpers & Jones, 2010).

Number (%)
63 (35.5)
37 (20.1)
23 (13.0)
13 (7.3)
13 (7.3)
12 (6.8)
7 (4.0)
5 (2.8)
4 (2.3)
15 (8.5)

The reserachers conducted their analysis using JMP v8.0 (SAS Institute) software and
ccomparisions for ordinal variables used a Fisher’s exact test while continuous variables
were analysed using a Wilcoxon’s rank sum test (Alpers & Jones, 2010). A logistic
regression analysis was used to evaluate the effects of age on the risk of acute renal
failure with patients who had exertional rhabdomyolysis against those from other causes
of rhabdomyolysis (Alpers & Jones, 2010). Last, a multivariate model was constructed to
evaluate the effects of age, gender, and body mass index agaisnt the risks of exertional
rhabdomyolysis in military trainees (Alpers & Jones, 2010). As was previously stated, the
results showed that the most common cause of rhabdomyolysis in this population was
exertional and that this exertional rhabdomyoylsyis was characterized by a low incidence
rate in the active population (Alpers & Jones, 2010). Alpers and Jones (2010) provided a
table outlining the comparision of millitary trainees with extertional rhabdomyolysis
versus those without it and demonstrated that no significant differences were noted
between the two groups:
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Trainees with
exertional
rhabdomyolysis
(n=44)

Trainees
Odds ratio
without
(95% CI)
exertional
rhabdomyolysis
(n=198,399)
20.5 (20.5-20.5)

P-value

0.052

Mean age,
years (95%
CI)

20.5 (19.8–
21.3)

Gender, %
male
Mean BMI,
kg/m2 (95%

88.6

75.5

24.3 (21.4–27.1)

23.2 (23.1-23.2)

CI)
Training during 45.5
summer
months, %
(Alpers & Jones, 2010).

40.2

2.53 (0.996.41)

0.86

0.08

0.81 (0.451.46)

0.54

Overtraining Syndrome
Overtraining Syndrome (OTS), as defined by Budgett (1998), “…is a condition of fatigue
and underperformance, often associated with frequent infections and depression which
occurs following hard training and competition” (p. 107). Consequently, OTS does not
resolve despite adequate rest and no identifiable medical cause (Budgett, 1998). Signs
and symptoms of OTS begin with an abnormal response to training when fatigue
becomes so significant that rest does not alleviate the symptoms. These signs and
symptoms range from hypotension, reduced maximum oxygen consumptions, postural
rise in the heart rate, heavy muscles, depression, sleep disturbances, increased emotional
ability, anxiety, irritability, and excessive sweating (Budgett, 1998). Frequently, athletes
may endure upper respiratory tract infections or other minor infections when they try to
return too quickly to training (Budgett, 1998). Only recently has OTS become a
commonplace term in the field of ultrarunning. An article published by Outside Magazine
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(2015) highlighted several athletes whose struggles with OTS have impaired their
training, racing, and livelihoods in different ways. According to the article, research is
still very early in its findings and the focus for doctors has been primarily on determining
the physiological causes of the condition (Brown, 2015). However, there is still not
consensus on the defining markers of OTS, which makes it difficult to diagnose, and
many doctors are more comfortable ruling out other possibilities before discussing OTS,
according to Brown (2015).
National Inpatient Sample (NIS)
The NIS database is a fraction of a family of databases and software tools that were
developed by the Healthcare Cost and Utilization Project (HCUP) (Healthcare Cost and
Utilization Project, 2015). This database possesses the largest publicly available all-payer
inpatient healthcare information in the United States (Healthcare Cost and Utilization
Project, 2015). Furthermore, the database contains more than seven million hospital stays
each year (unweighted). When census data is considered weighted, it is estimated that the
NIS covers more than thirty-six million hospitalizations (Healthcare Cost and Utilization
Project, 2015). The NIS was developed by the Agency for Healthcare Research and
Quality (AHRQ) through a Federal-State-Industry partnership, which now informs
decisions made at the national, state, and community levels (Healthcare Cost and
Utilization Project, 2015). Key features of the most recent NIS from 2012 include:


The NIS is drawn from all States participating in HCUP, representing more than
95 percent of the U.S. population.



The NIS approximates a 20-percent stratified sample of discharges from U.S.
community hospitals, excluding rehabilitation and long-term acute care hospitals.
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The self-weighting design of the new NIS reduces the margin of error for
estimates and delivers more stable and precise estimates than previous versions of
the NIS.



The NIS protects patient confidentiality because State and hospital identifiers are
no longer provided.



The new NIS retains a large sample size, which enables analyses of rare
conditions, uncommon treatments, and special patient populations.
(Healthcare Cost and Utilization Project, 2015).

NIS data are used to describe incidences of specific diagnoses in healthcare.
Day, Lau, Ong, Williams, Ramsey, and Kurtz (2010), used the NIS database to examine
trends in upper extremity arthroplasty in the United States as a function of race, age,
gender, and census region. Their study examined surgical procedures identified from
discharge records by using the International Classification of Diseases, 9th Revision
Clinical Modification (ICD-9-CM) and highlighted codes 81.80 (total shoulder
arthroplasty, 81.81 (hemishoulder arthroplasty), and 81.84 (total elbow arthroplasty).
Using a Poisson regression model, age, race, census region, gender, and calendar year
were used as covariates to account for any differences in prevalence among population
subgroups and changes over time (Day, et al., 2010). To calculate surgery prevalence, the
authors divided the number of estimated procedures from the NIS population subgroups
by the corresponding population estimates and Census Bureau projections. They found
national trends and projections in upper extremity arthroplasty were comparable to total
knee arthroplasty and that this rising number of arthroplasty procedures, in conjunction
with increasing charges, had the potential to increase financial strains on healthcare
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systems (Day, et al., 2010).
In a subsequent case study, Karmacharya, Pathak, Aryal, Giri, and Donato (2015)
studied the seasional variation in acute gouty arthritis using the NIS database. The
authors examined the variation in incidences of acute gout by identifying patients over
age eighteen with a primary diagnosis of acute gouty arthritis, as classified by the ICD-9CM coding system, during hospitalizations that occurred from 2009-2011. An Edward’s
recognition and estimation method was used to show cyclic trends, while a a Z-test was
used to compare the seasonal incidences. The results showed a peak incidence of acute
gouty arthritis in November, while overall, the hightest number of hospitlizations was in
the autumn months (peak/low ratio = 1.34% versus 1.29-1.38%) (Karmacharya, Pathak,
Aryal, Giri, & Donato, 2015). The lowest incidence was observed in the Spring with a
peak/low ratio of 28.12% versus 23.13% (Karmacharya, Pathak, Aryal, Giri, & Donato,
2015).
International Classification of Diseases, 9th Revision Clinical Modification (ICD-9CM)
The Centers for Disease Control and Prevention define ICD-9-CM as “…the official
system of assigning codes to diagnoses and procedures associated with hospital
utilization in the United States” (Centers for Disease Control and Prevention, 2013, para.
1). ICD-9-CMs were also used in the coding and classification of mortality data from
death certificates until 1999, at which point a switch to ICD-10 occurred (Centers for
Disease Control and Prevention, 2013). ICD-9-CM is comprised of:


A numerical list of the disease code numbers in tabular form



An alphabetical index to the disease entries; and
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Classification system for surgical, diagnostic, and therapeutic procedures
(alphabetic index and tabular list)
(Centers for Disease Control and Prevention, 2013, para. 2).

Both the National Center for Health Statistics (NCHS) and the Centers for Medicare and
Medicaid Services are the United States government agencies who are responsbile for
managaing any changes and modifications to the ICD-9-CM (Centers for Disease Control
and Prevention, 2013).
To specifically define rhabdomyolysis, we will need to evaluate ICD-9-CM code 728.88.
Secondarily, we will need to exclude acute renal failure (ARF), ICD-9-CM 584, and its
subclassifciations, as this disease process and sequelae are too broad. Polderman (2004)
wrote “Rhabdomyolysis can develop in any circumstances where energy demands in
muscles exceed the available energy supplies; it accounts for between 2 and 5% of all
cases of acute renal failure in the ICU” (p. 1030). Rhabdomyolysis is infrequent but still
an important cause of renal failure in the critical care setting (Polderman, 2004).
ICD-9 Codes were chosen for this study to maintain a consistent link to the diagnoses
that were obtained from 2001 through 2013. The United States recently switched to a
new coding system of ICD-10, which foundationally alters the coding patterns.
United States (US) Census Bureau
The US Census Bureau, formed in 1942, is a part of the US Department of Commerece
and is overseen by the Economics and Statistics Administration (The United States
Census Bureau, 2015). The Bureau’s mission “…is to serve as the leading source of
quality data about the nation's people and economy. We honor privacy, protect
confidentiality, share our expertise globally, and conduct our work openly” (The United
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States Census Bureau, 2015, para. 1). Operating under US Codes Title 13 and Title 26,
the Bureau collects six different forms of data and information:
1. Decennial Census of Population and Housing - The U.S. Census counts every
resident in the United States. It is mandated by Article I, Section 2 of the
Constitution and takes place every 10 years.
2. Economic Census - The Economic Census is the U.S. Government's official fiveyear measure of American business and the economy.
3. Census of Governments - Identifies the scope and nature of the nation's state and
local government sector including public finance and public employment and
classifications.
4. American Community Survey (ACS) - The American Community Survey (ACS)
is a mandatory, ongoing statistical survey that samples a small percentage of the
population every year.
5. Our Surveys and Programs - Our surveys provide periodic and comprehensive
statistics about the nation, critical for government programs, policies, and
decision-making.
6. Economic Indicators - The Census Bureau releases fourteen different reports on
key economic indicators. Each indicator is released on a specific schedule.
(The United States Census Bureau, 2015).
A US Census search from 2013 yields a result of 46,807,902 (Margin of Error +/- 3,3770
and 18,413) males between the ages of 18 and 40 (The United States Census Bureau,
2013). This result will provide the denominator for this study, as the NIS data for
rhabdomyolysis will provide the numerator. With this information, we will calculate the
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rate of injury in a state per 100,000 males.
Emergency Department Coding
Part of the Federal Balanced Budget Act of 1997 required the Centers for Medicare and
Medicaid Services (CMS) to create a new Outpatient Prospective Payment System
(OPPS) for Medicare, which is similar to Medicare’s prospective payment system, called
Diagnosis Related Groups (DRG) (American College of Emergency Physicians, 2011).
Emergency Departments also have Ambulatory Payment Classifications (APC), which
are the government’s form of payment for a facility’s outpatient services in Medicare
(American College of Emergency Physicians, 2011). Research into the coding practices
of Emergency Departments (ED) in the U.S. show that there is no national standard for
hospital assignment of evaluation and management (E&M) code levels in the ED
(American College of Emergency Physicians, 2011). However, the use of Healthcare
Common Procedure Coding System (HCPCS) codes must reasonably relate the intensity
of a hospital’s resources and the hospital may bill visit codes based on their own coding
guidelines (American College of Emergency Physicians, 2011). The American College of
Emergency Physicians (ACEP) states coding guidelines should promulgate clear and
accurate payments, only required documentation that is clinically necessary to facilitate
patient care, and should not promote any sort of upcoding or gaming (American College
of Emergency Physicians, 2011). E codes are an additional set of codes ED’s use to
“…capture the external cause of injury or poisoning, the intent and the place where the
event occurred” (American College of Emergency Physicians, 2014, para. 11). The use of
these codes is dependant upon the individual institution and state, but are generally not
mandatory (American College of Emergency Physicians, 2014). It is important for
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institutions to contact their current and prospctive payers to ensure they will process these
codes. For this research, possible E codes may include:


E001: Activities involving walking and running
o E001.1: Activities involving running



E927: Overexertion and strenuous movements
o E927.2: Excessive physical exertion
o E927.3: Cumulative trauma from repetitive motion
o E927.4: Cumulative trauma from repetitive impact
o E927.8: Other overexertion and strenuous and repetitive movements or
loads
o E927.9: Unspecified overexertion and strenuous and repetitive movements
or loads
(ICD9Data.com, n.d.).

Summary
The literature review found an assortment of research studies, but none that provide an
in-depth, analyses into the prevalence of ultrarunning in young adult males. This research
will determine the magnitude of ultrarunning rhabdomyolysis and any patterns that may
group patients geographically and by age.

CHAPTER III
METHODOLOGY

Research Design
Our research study will use a retrospective analysis on historical emergency department
patients admitted with the diagnosis of rhabdomyolysis, provided by HCUPS data. With
this data, we will have the ability to present 10 year trends for each state from 2001 to
2011, and how these rates parallel the growth of ultrarunning in the United States over
time. The two research questions to be studied will be:
1. Does ED diagnoses of rhabdomyolysis in young adult males parallel the growth in
ultrarunning?
2. Are there geographic and seasonal variations in the population rate of ER, which
correspond to locations and times where most training for ultrarunning events
occurs?
National ED admission data from each state will use ICD-9-CM code of 728.88. All
patients with a diagnosis of infection, cancer, trauma, diabetes, or heart disease were
excluded from the data set.
Data Analysis
The data analysis will consist of a multi-variant regression analysis to assess the
rhabdomyolysis trends over time. U.S. Census data will be used to calculate a population
rate for rhabdomyolysis by state. Data from UltraRunning.com will be used to calculate
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the number of events per year. The ten-year trends in time for the prevalence of
ultrarunners with rhabdomyolysis will be compared to the growth of ultrarunning using a
run-time graph

CHAPTER IV
RESULTS/FINDINGS
The results of the study were analyzed using a retrospective analysis on historical
emergency department patients admitted with the diagnosis of rhabdomyolysis from
years 2004 to 2012, as provided by HCUPS. The frequencies of rhabdomyolyses were
compared to 2009 through 2013 U.S. Census data to calculate a population rate for
rhabdomyolysis by state. Data from UltraSignUp.com were used to calculate the number
of races in each state by month, from November 2015 through to planned races in
December of 2016. Table 3 demonstrates the aggregation of these data using Microsoft
Excel. Once the frequency was obtained, a rhabdomyolysis rate was calculated for each
state using a simple calculation of (frequency/state population)*100,000. Table 3
demonstrates the aggregation of these data:
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Table 3

As the data show, California leads in overall volume of races, peaking in May and
August, which avoids the extreme heats of summer. October and May are the most
populous in regards to their number of races. This in effect is due to the historically
cooler months in Washington (September), Oregon (October), and Colorado (September).
Conversely, historically cooler states such as Alaska (August), Montana (August), &
Utah (July) see their peak in races in the middle of the year. California remains an outlier
as their races spread the spectrum of the calendar with February, May, August, and
October all sharing almost equal volume in the number of races they host.
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Table 4
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Table 5 shows the distribution of races by state and month:
Table 5
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In Table 6, we see that the U.S. Census population data from 2009 through 2013 were
used to calculate an overall race rate by state and quarter for males 18-40 per 100,000.
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Table 6 Race Rate by State and Quarter

Subsequently, these U.S. Census data were then used to calculate rhabdomyolysis rates
by state for years 2004 to 2012. An average of for each year was totaled at the bottom of
the graph.
An aggregation of the racing data, combined with the U.S. Census population data,
demonstrate an increase in Quarter 3 overall racing and a rate of 0.27 per 100,000 of
males 18-40. This result accepts the study’s hypothesis that there are geographic and
seasonal variations in the population rate of ER. Similarly, there are seasonal variations
with the locations and times where most training for ultrarunning events occur.
Geographic variation is illustrated in both Tables 3 and 4. The seasonality and geographic
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trends share similar peaks in volume with the states that see a large volume of races and
rhabdomyolysis diagnoses.
In order to answer the second hypothesis, Does ED diagnoses of rhabdomyolysis in
young adult males parallel the growth in ultrarunning, the researchers established Table 7
which calculates the rhabdomyolysis frequency and rate for years 2004 to 2012 using the
basis of 2013 U.S. Census data as the denominator.
Table 7

These rates are further displayed graphically, and seasonally, in Table 8 to show trends in
the data:
Table 8
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Table 9 shows both the frequency and rate of rhabdomyolysis diagnoses by state for each
corresponding year:
Table 9

Using SPSS software, we were able to calculate a linear regression using ANOVA to
capture significance. The table below demonstrates the significance values for years 2004
through 2012:

Table 10
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Last, the data were assembled on a single run-time chart to depict an overlay of races,
rhabdomyolysis rate, and rhabdomyolysis frequency. This chart accepts the second
hypothesis as noted in Table 11:

Table 11

CHAPTER V
DISCUSSION
Discussion of Results
As we noted in Chapter Four, our research has demonstrated a rise in the incidence of
rhabdomyolysis that mirrors the rise of long-distance ultra running. The ten-year trends
favor both a gradual increase in rhabdomyolysis rate and ultra running races but we have
realized a significant increase in the frequency of rhabdomyolysis from 2011 to 2012. As
one would anticipate, the states with the largest amount of races, typically accounted for
the largest number of rhabdomyolysis frequencies and rates. Specifically, California and
New York are exemplary but Colorado and Utah (both with high levels of races) have
lower rates and frequencies of rhabdomyolysis. Texas, Florida, and North Carolina’s
rates/frequencies could be explained by their overall populations and favorably warmer
climate. In Chapter Two, we discussed extreme temperatures such as heat, which can
induce rhabdomyolysis and rhabdomyolysis symptoms. The Alpers and Jones (2010)
study noted that of their 177 subjects, 35.5% of them had rhabdomyolysis caused by
physical exertion. That association discussed in their study could lend to speculation that
a significant portion of the rhabdomyolysis rates and frequencies were caused by physical
exertion, and particularly the type of extreme physical exertion that is associated with
long-distance ultra running. Last, a Significance of 0.031 was noted using SPSS software
(version 23).
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Limitations
A number of limitations implicated our study as we have outlined:
1. U.S. Census Bureau Community Survey data for 2009 through 2013 were
used as the denominator to calculate statewide rates by year. Further studies
should expand this denominator to sample a larger population.
2. The number of ultra running races was only obtained through one website’s
database from years 2015 to 2016. Further studies should be expanded to
include multipole databases and historical information to properly calculate
these races over time.
3.

The study was limited by the use of ICD-9 Codes that do not contain a direct
association with ultra running induced rhabdomyolysis. To truly understand
whether the rise in rhabdomyolysis diagnoses in young adult males is directly
correlated to the rise in ultra running, we will need a classification system that
provides granular levels of diagnosis codes, such as ICD-10, and the use of Ecodes in the Emergency Department.

4. A secondary study should further examine the specific biomarkers as they
pertain to the diagnosis for rhabdomyolysis. Skenderi, Kavouras, Anastasiou,
Yiannakouris, and Matalas’ (2006) have begun this process but ideally, these
biomarkers would be drawn throughout the race, pre, and post in large sample
sizes to draw meaningful conclusions and any correlations to distance,
seasonality, and exertion.
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Summary
This body of research provides an introductory examination into the ten-year trends in
emergency department diagnoses of rhabdomyolysis in young adult males, and whether
or not these diagnoses parallel the growth in long distance ultra running. We concluded
that they do parallel each other but this research lends itself to limitations that require
further analysis. Furthermore, we were able to capture the average cost for a hospital
admission of rhabdomyolysis, $9,946 USD (SD $19,659). If we hypothesize multiplying
the $9,946 by the 22,316 occurrences of rhabdomyolysis, then there exists a potential for
$221,954,936 USD in cost-avoidance that requires a deep analysis into the societal
impacts of diagnosis.
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